Future studies should assess whether IL-10 enhancement through sleep and circadian interventions directly impacts macrophage phenotypic shifts, extracellular matrix remodeling, and joint capsule fibrosis resolution in FS patients, providing a clearer mechanistic understanding of its therapeutic relevance. This evidence concerns the gene IL10 and Feingold syndrome.